Ofatumumab is chemotherapy and targeted therapy drug which is available in two brand names Arzerra and Kesimpta. Arzerra is approved for Chronic lymphocytic leukemia whereas Kesimpta is approved for Relapsing multiple sclerosis.
Category:
O
-
-
Obinutuzumab is a targeted therapy drug used to treat Chronic Lymphocytic Leukemia and Follicular lymphoma.
